In a murine xenograft model of lung cancer, endostatin treatment led to a reduction in the number of M2 - like TAMs and TEMs in the tumors, and an increase in the number of M1 - like TAMs (although not statistically significant). This evidence concerns the gene COL18A1 and lung carcinoma.